Monday the convention seemed like old times. Apparently, most U.S. radiologists waited until Sunday to come to the meeting, as I saw far more recognizable faces the second day. I guess they like leftover turkey more than I do.
Monday the convention seemed like old times. Apparently, most U.S. radiologists waited until Sunday to come to the meeting, as I saw far more recognizable faces the second day. I guess they like leftover turkey more than I do.
We were only outnumbered about 25 to one. This is truly an international collection.
I listened to an interesting discussion of the American College of Radiology's guidelines for practice. The mammography lexicon and standards were particularly hot. I always thought it makes sense to have a standard language. The problem is lawyers.
Lawyer: "I see you discovered a 2-mm nodule in Mrs. Lowly Victim's breast on a screening mammo".
Me: "Yes."
Lawyer: "And by the time she had special views, saw a surgeon, and had it excised, it had swelled to nearly twice that size."
Me: "Yes, I believe it was just under 4 mm when they took it out."
Lawyer: "So, if you had not ignored the national standards for your profession, if you did not send out reports your own Professional College would say are bad, if you had not called this terrible lesion a 'nodule' instead of a 'mass,' poor Mrs. Victim might have been rid of this rapidly growing tumor sooner. Tell me, Doctor, should we assume you ignore all the standards of your profession, since you clearly ignored these?"
Me: quiet babbling and drooling.
Standards and guidelines are a good thing, but they are clearly a two-edged sword.
I also attended several sessions of a case-based course on neuroradiology. I got six hours of CME, which is more than I usually get the entire time I'm at this meeting. The course and the format were excellent, but it cost me a day of roaming around in the technical and scientific exhibits.
I wish I could figure out how to do more of what is available every day without staying at McCormick Place any later. Of course, I have the same problem at home.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.